Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Leite de Oliveira

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cell|May 15, 2018
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic PotentialLiqin Wang, Rodrigo Leite de Oliveira, Sanne Huijberts, et al.
Cancer Cell|August 18, 2012
Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicityRodrigo Leite de Oliveira, Sofie Deschoemaeker, Anne-Theres Henze, et al.
Plos One|September 6, 2022
Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activityZiva Pogacar, Jackie L Johnson, Lenno Krenning, et al.
Cell Reports|August 4, 2015
The Cancer Cell Oxygen Sensor PHD2 Promotes Metastasis via Activation of Cancer-Associated FibroblastsAnna Kuchnio, Stijn Moens, Ulrike Bruning, et al.
Nature|October 11, 2011
Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesisYukiji Takeda, Sandra Costa, Estelle Delamarre, et al.
Cancer Research|November 19, 2025
Estrogen Production in Pancreatic Cancer Shapes a Tumor Suppressive Stromal MicroenvironmentPaul Manoukian, Deni M van Schie, Anne-Sophie van Schelt, et al.
Nature|October 4, 2019
Inducing and exploiting vulnerabilities for the treatment of liver cancerCun Wang, Serena Vegna, Haojie Jin, et al.
Cell|February 17, 2009
Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalizationMassimiliano Mazzone, Daniela Dettori, Rodrigo Leite de Oliveira, et al.
Nature Cancer|November 22, 2022
cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysisLiqin Wang, Haojie Jin, Fleur Jochems, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2024
A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in BRAFV600-Mutated MelanomaAlaa Embaby, Sanne C F A Huijberts, Liqin Wang, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cell|May 15, 2018
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic PotentialLiqin Wang, Rodrigo Leite de Oliveira, Sanne Huijberts, et al.
Cancer Cell|August 18, 2012
Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicityRodrigo Leite de Oliveira, Sofie Deschoemaeker, Anne-Theres Henze, et al.
Plos One|September 6, 2022
Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activityZiva Pogacar, Jackie L Johnson, Lenno Krenning, et al.
Cell Reports|August 4, 2015
The Cancer Cell Oxygen Sensor PHD2 Promotes Metastasis via Activation of Cancer-Associated FibroblastsAnna Kuchnio, Stijn Moens, Ulrike Bruning, et al.
Nature|October 11, 2011
Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesisYukiji Takeda, Sandra Costa, Estelle Delamarre, et al.
Cancer Research|November 19, 2025
Estrogen Production in Pancreatic Cancer Shapes a Tumor Suppressive Stromal MicroenvironmentPaul Manoukian, Deni M van Schie, Anne-Sophie van Schelt, et al.
Nature|October 4, 2019
Inducing and exploiting vulnerabilities for the treatment of liver cancerCun Wang, Serena Vegna, Haojie Jin, et al.
Cell|February 17, 2009
Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalizationMassimiliano Mazzone, Daniela Dettori, Rodrigo Leite de Oliveira, et al.
Nature Cancer|November 22, 2022
cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysisLiqin Wang, Haojie Jin, Fleur Jochems, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2024
A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in BRAFV600-Mutated MelanomaAlaa Embaby, Sanne C F A Huijberts, Liqin Wang, et al.
Pageof 3